Zucara Therapeutics Competitors and Similar CompaniesClear all

Zucara Therapeutics's competitors and similar companies include Sensulin, Novaremed, Pila Pharma and Praetego.
Zucara Therapeutics
Zucara Therapeutics
Zucara Therapeutics is a company developing drug therapies to prevent hypoglycemia in people with diabetes.
Sensulin
Sensulin
Sensulin is a biotechnology company developing insulin for diabetes.
Novaremed
Novaremed
Novaremed is a clinical-stage biopharmaceutical company.
Pila Pharma
Pila Pharma
Pila Pharma is a clinical-stage pharmaceutical company.
Praetego
Praetego
Praetego is a preclinical stage pharmaceutical company committed to addressing serious diabetic complications.
Founding Date
Founding Date
2015
Founding Date
2011
Founding Date
2017
Founding Date
2014
Founding Date
2017
Type
Type
Private
Type
Private
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
Toronto, CA HQ
Locations
Oklahoma City, US HQ
San Diego, US
Locations
Basel, CH HQ
Locations
Malmö, SE HQ
Locations
Durham, US HQ
Employees
Employees
11
Employees
8
Employees
10
Employees
9
Employees
4

Funding

Latest funding round
Latest funding round
$ 3.9m (about 6 years ago)
Latest funding round
$ 2.7m (over 10 years ago)
Latest funding round
$ 2.6m (almost 7 years ago)
Latest funding round
N/A
Latest funding round
N/A
Total funding raised
Total funding raised
$ 24.9m
Total funding raised
$ 3.1m
Total funding raised
$ 13.3m
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Sensulin
HQ
Oklahoma City, US
Employees
8

Sensulin is a biotechnology company developing insulin for diabetes.

View company
Novaremed
HQ
Basel, CH
Employees
10

Novaremed is a clinical-stage biopharmaceutical company.

View company
Pila Pharma
HQ
Malmö, SE
Employees
9

Pila Pharma is a clinical-stage pharmaceutical company.

View company
Praetego
HQ
Durham, US
Employees
4

Praetego is a preclinical stage pharmaceutical company committed to addressing serious diabetic complications.

View company